关 于 河南金丹乳酸科技股份有限公司 2023 年限制性股票激励计划作废部分已授予 但尚未归属的限制性股票暨调整授予价格的 法律意见书 北京植徳律师事务所 植德（证）字[2023]044-5 号 二〇二四年九月 北京植德律师事务所 Merits & Tree Law Offices 北京市东城区东直门南大街 1 号来福士中心办公楼 12 层 邮编：100007 5 thFloor, Raffles City Beijing Office Tower, No.1 Dongzhimen South Street, Dongcheng District, Beijing 100007 P.R.C 电话（Tel）：010-56500900 传真（Fax）：010-56500999 www.meritsandtree.com 释 义 注：如无特别说明，本法律意见书中若出现尾数与各分项数值之和不相符合的情形， 均为四舍五入所致。 1 本法律意见书中，除非文义另有所指，下列词语或简称具有如下含义： 金丹科技/公司 指 河南金丹乳酸科技股份有限公司 本次激励计划 指 河南金丹乳酸科技股份有限公司实施的2023年限制性股 票激 ...

| 证券代码：300829 | 证券简称：金丹科技 | 公告编号：2024-067 | | --- | --- | --- | | 债券代码：123204 | 债券简称：金丹转债 | | 河南金丹乳酸科技股份有限公司 关于调整限制性股票授予价格、作废部分已授予 但尚未归属的限制性股票及预留权益失效的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 河南金丹乳酸科技股份有限公司（以下简称公司、金丹科技）于 2024 年 9 月 27 日召开第五届董事会第十八次会议与第五届监事会第十五次会议，审议通 过了《关于调整公司限制性股票授予价格、作废部分已授予但尚未归属的限制性 股票及预留权益失效的议案》，具体情况如下： 一、限制性股票激励计划已履行的审批程序 公司 2023 年限制性股票激励计划（以下简称本次激励计划）已经履行的审 批程序如下： 1．2023 年 9 月 8 日，公司召开第五届董事会第六次会议，审议通过了《关 于公司<2023 年限制性股票激励计划（草案）>及其摘要的议案》《关于公司<2023 年限制性股票激励计划实施考核管理办法>的议案》《关于提请 ...

河南金丹乳酸科技股份有限公司 第五届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 河南金丹乳酸科技股份有限公司（以下简称公司）第五届董事会第十八次 会议于 2024年 9月 27日上午 9:00会议以现场结合通讯方式在公司会议室召开， 会议通知于 2024 年 9 月 24 日以电话及电子邮件方式发出。 本次会议由公司董事长张鹏先生主持。本次会议应出席董事 7 名，实际出 席董事 7 名，其中余龙、张复生、赵永德以通讯表决方式出席会议。公司监事、 高级管理人员列席了会议。本次会议的召集和召开符合国家有关法律、法规及 《公司章程》的规定，决议合法有效。 | 证券代码：300829 | 证券简称：金丹科技 | 公告编号：2024-065 | | --- | --- | --- | | 债券代码：123204 | 债券简称：金丹转债 | | 根据公司《激励计划》相关规定，公司预留的 15 万股限制性股票，应当在 本次激励计划经公司股东大会审议通过后 12个月内授出，超过 12个月未明确激 励对象的，预留权益失效。 ...

| 证券代码：300829 | 证券简称：金丹科技 | 公告编号：2024-064 | | --- | --- | --- | | 债券代码：123204 | 债券简称：金丹转债 | | 河南金丹乳酸科技股份有限公司 持股5%以上股东减持股份预披露公告 持股 5%以上股东广州诚信创业投资有限公司保证向公司提供的信息内容 真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示： 持有河南金丹乳酸科技股份有限公司（以下简称本公司、公司或发行人）股 份 1,163.19 万股（占本公司总股本比例 6.32%）的股东广州诚信创业投资有限公 司（以下简称广州诚信）计划在本公告披露之日起 15 个交易日后的 3 个月内（即 2024 年 10 月 11 日至 2025 年 1 月 10 日）以集中竞价、大宗交易及法律、法规 允许的其他方式减持本公司股份不超过 550 万股（占本公司总股本比例 2.99%）。 本公司于近日收到广州诚信发来的《广州诚信创业投资有限公司关于减持金 丹科技股份的告知函》，广州诚信拟减持所持有的本公司部分股份，现将有关 ...

| 证券代码：300829 | 证券简称：金丹科技 | 公告编号：2024-063 | | --- | --- | --- | | 债券代码：123204 | 债券简称：金丹转债 | | 河南金丹乳酸科技股份有限公司 关于使用闲置募集资金及自有资金进行现金管理的进展 公告 1 | 中国民生银行 股份有限公司 | 聚赢汇率-挂钩欧元 对美元汇率结构性 | | 保本浮 | 2024年9 | 2024年9 | 1.20%- | | 募集资 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 13,280 | 动收益 | | | | 722693967 | | | 郑州纬三路支 | 存款 | | 型 | 月2日 | 月18日 | 1.83% | | 金 | | 行 | （SDGA241591Z） | | | | | | | | | 中国民生银行 股份有限公司 郑州分行营业 | 聚赢汇率-挂钩欧元 对美元汇率结构性 存款 | 2,000 | 保本浮 动收益 | 2024年8 月20日 | 2024年9 月3日 | 1.20%- 1.85% | ...

| 证券代码：300829 | 证券简称：金丹科技 公告编号：2024-062 | | --- | --- | | 债券代码：123204 | 债券简称：金丹转债 | 根据《深圳证券交易所上市公司自律监管指引第 9 号--回购股份》等相关规 定，公司应当在回购期间每个月的前三个交易日内披露截至上月末的回购进展情 况。现将公司截至上月末的回购股份进展情况公告如下： 一、股份回购进展情况 截至 2024 年 8 月 31 日，公司通过股份回购专用证券账户以集中竞价交易方 式回购公司股份 2,079,180 股，占公司总股本的 1.12%，最高成交价为 15.50 元/ 股，最低成交价为 13.23 元/股，成交总金额为人民币 30,041,503.90 元（不含交 易税费）。本次回购符合公司回购股份方案及相关法律法规的要求。 二、其他说明 （一）公司回购股份的时间、回购股份数量及集中竞价交易的委托时段、交 易价格等符合《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》及 公司回购股份方案的相关规定，具体如下： 河南金丹乳酸科技股份有限公司 关于股份回购进展的公告 本公司及董事会全体成员保证信息披露的内容 ...

河南金丹乳酸科技股份有限公司 2024 年半年度非经营性资金占用及其他关联资金往来情况汇总表 单位：万元 法定代表人： 主管会计工作负责人： 会计机构负责人： | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公 | 上市公司核算 | 年期初 2024 | 2024 年半年度占 用累计发生金额 | 2024 年半年度 占用资金的利息 | 2024 年半年 度偿还累计 | 2024 年半年 度期末占用 | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 司的关联关系 | 的会计科目 | 占用资金余额 | | | | | | | | | | | | | （不含利息） | （如有） | 发生金额 | 资金余额 | | | | 控股股东、实际控制人 | | - | | - | | - | | - | | - | | 及其附属企业 | | - | | - | | - | | - | | - | | 小计 | - | - | - | | | | | | | - | | 前控股股东、实 ...

Financial Performance - The company's operating revenue for the first half of 2024 was CNY 737,028,342.98, representing a 2.25% increase compared to CNY 720,798,683.27 in the same period last year[24]. - The net profit attributable to shareholders of the listed company reached CNY 61,285,615.90, an increase of 17.30% from CNY 52,248,932.47 in the previous year[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 49,527,593.07, up 18.34% from CNY 41,851,758.98 year-on-year[24]. - The net cash flow from operating activities was CNY 152,888,709.46, reflecting a 29.14% increase compared to CNY 118,391,569.32 in the same period last year[24]. - Basic earnings per share were CNY 0.34, a 17.24% increase from CNY 0.29 in the previous year[24]. - Total assets at the end of the reporting period were CNY 3,404,828,947.05, a slight increase of 0.10% from CNY 3,401,570,403.32 at the end of the previous year[24]. - The net assets attributable to shareholders of the listed company increased by 5.75% to CNY 1,802,201,888.86 from CNY 1,704,257,520.83 at the end of the previous year[24]. - The weighted average return on net assets was 3.53%, up from 3.37% in the previous year[24]. - The company reported a fully diluted earnings per share of CNY 0.3292 based on the latest share capital[24]. Investment and Capital Management - The company plans not to distribute cash dividends or issue bonus shares[4]. - The company has a total of 6.47 million in other financial assets, with a decrease of 2.54 million attributed to receivables financing[99]. - The total amount of raised funds is 123,129.06 million, with 3,438.36 million utilized during the reporting period[102]. - Cumulative investment of raised funds reached 82,465.59 million, with 32,113.58 million allocated for working capital[106]. - The company has established special accounts for raised funds at multiple banks to ensure proper management and usage[105]. - The company has reported a total expected surplus of 125.89 million RMB in raised funds for the "Annual Production of 50,000 Tons of High-Purity L-Lactic Acid Project," primarily due to cost savings from project management and resource optimization[110]. - The company has received approval for the temporary use of up to 100 million RMB of idle raised funds to supplement working capital, which was fully returned by October 14, 2022[110]. - The company has effectively managed idle raised funds through cash management to maximize fund utilization efficiency[110]. Production and Operational Efficiency - The company has an annual production capacity of 183,000 tons of lactic acid and its derivatives, positioning it as an industry leader[43]. - The company achieved a production capacity of 183,000 tons of lactic acid and its derivatives, maintaining its leading position in the domestic lactic acid industry[61]. - The production volume of lactic acid rose by 24.46% year-on-year, totaling 74,610.74 tons in the first half of 2024[74]. - The sales volume of lactic acid increased by 14.49% year-on-year, reaching 72,272.65 tons in the first half of 2024[74]. - The company is focusing on vertical integration of the biodegradable materials supply chain to reduce transportation costs and enhance competitiveness[43]. - The company is committed to developing new technologies to optimize the production process and reduce costs, enhancing the applicability of biodegradable materials[45]. Market and Sales Strategy - The company has established a sales network across all provinces in China and exports to over 90 countries and regions globally[78]. - The company is actively pursuing market expansion through new product development and technological advancements in the biodegradable materials sector[97]. - The company is implementing a differentiated product mix strategy to enhance product benefits and is actively developing new customers and markets for high-value salt products[57]. - The company has reduced the number of domestic distributors by 87, a decrease of 16.89% compared to the previous period[70]. - The company’s foreign sales revenue was CNY 272,728,377.52, with a gross margin of 16.75%, indicating a year-on-year increase of 16.46% in revenue[70]. Research and Development - The company has established a comprehensive R&D system with 43 invention patents and multiple non-patent technologies[76]. - The company is exploring modern agricultural practices to control corn procurement costs through the establishment of a subsidiary[126]. - The company has established partnerships with several universities for R&D in new products and processes, aiming to enhance the lactic acid industry chain[126]. - The company is committed to continuous improvement in fermentation technology to enhance production efficiency and reduce costs[126]. Environmental and Social Responsibility - The company strictly adheres to environmental protection laws and regulations, including the Environmental Protection Law and the Water Pollution Prevention and Control Law of the People's Republic of China[145]. - The company has increased its investment in environmental governance and protection, regularly paying environmental protection taxes each quarter[151]. - The company has donated a total of 2.3 million RMB to social welfare initiatives, including 500,000 RMB to support education for underprivileged children in March 2024[156]. - The company actively participates in social responsibility audits to enhance its corporate social responsibility environment[156]. Risk Management - The company is facing risks related to corn price fluctuations, which significantly impact production costs, as corn accounts for a large portion of the cost of lactic acid and its derivatives[125]. - The company has implemented strict risk control measures for its hedging activities, including optimizing positions and ensuring compliance with regulations[125]. - The company plans to optimize production processes and increase R&D investment to mitigate risks associated with declining product prices due to competition[128]. - The company will closely monitor and analyze exchange rate fluctuations, adjusting export product prices accordingly to mitigate exchange rate risks[129]. Corporate Governance - The company has undergone changes in project implementation locations and investment amounts, which have been approved by the board and shareholders[110]. - The company has fulfilled all commitments related to the issuance of convertible bonds as of the reporting date[159]. - The company has not engaged in any asset or equity acquisitions or sales during the reporting period[167]. - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period[195].

一、董事会会议召开情况 河南金丹乳酸科技股份有限公司（以下简称公司）第五届董事会第十七次 会议于 2024 年 8 月 27 日上午 9:00 以现场方式在公司会议室召开，会议通知于 2024 年 8 月 17 日以电话及电子邮件方式发出。 本次会议由公司董事长张鹏先生主持。本次会议应出席董事 7 名，实际出 席董事 7 名，全部董事出席会议。公司监事、高级管理人员列席了会议。本次 会议的召集和召开符合国家有关法律、法规及《公司章程》的规定，决议合法 有效。 二、董事会会议审议情况 经与会董事充分讨论，本次会议审议并通过了如下议案： | 证券代码：300829 | 证券简称：金丹科技 | 公告编号：2024-057 | | --- | --- | --- | | 债券代码：123204 | 债券简称：金丹转债 | | 河南金丹乳酸科技股份有限公司 第五届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 （一）审议通过《关于公司<2024 年半年度报告>及其摘要的议案》。 经审议，董事会认为：公司编制的《2024 年半年度报告》全文及其 ...

国金证券股份有限公司 关于河南金丹乳酸科技股份有限公司 2024 年半年度持续督导跟踪报告 | 保荐机构名称：国金证券股份有限公司 | 被保荐公司简称：金丹科技 | | --- | --- | | 保荐代表人姓名：朱垚鹏 | 联系电话：021-68826801 | | 保荐代表人姓名：解 明 | 联系电话：021-68826801 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | - | | (1)是否及时审阅公司信息披露文件 | 是 | | (2)未及时审阅公司信息披露文件的次数 | 0 | | 2.督导公司建立健全并有效执行规章制度的情况 | - | | (1)是否督导公司建立健全规章制度(包括但不限于防 止关联方占用公司资源的制度、募集资金管理制度、 | 是 | | 内控制度、内部审计制度、关联交易制度) | | | (2)公司是否有效执行相关规章制度 | 是 | | 3.募集资金监督情况 | - | | (1)查询公司募集资金专户次数 | 每月查询 | | (2)公司募集资金项目进展是否与信息披露文件一致 | 是 | | 4.公司治理督导情 ...